Tag Archives: Afatinib

Afatinib Extend Time to Tumor Progression in Advanced Lung Cancer

Currently, no treatment exists for lung cancer patients with epidermal growth-factor receptor (EGFR) mutation who have failed tyrosine kinase inhibitors, getifinib (Iressa) or erlotinib (Tarceva).  However, an investigational drug, afatinib (BIBW 2992), was recently found to increase progression-free survival and … Continue reading

Posted in Cancer, Lung Cancer, Non Small Cell Lung Cancer | Tagged , , , , , , , , , , , , | Comments Off on Afatinib Extend Time to Tumor Progression in Advanced Lung Cancer